The Trump administration has abandoned plans for tariffs on imported generic drugs, a move bringing significant relief to Indian pharmaceutical companies. This decision averts potential price hikes and shortages for millions of Americans relying on affordable Indian generics for various health conditions, highlighting India’s crucial role as the largest supplier of these essential medicines to the US.
Trade war: White House drops generic drug tariffs; eases pain for US patients & Indian pharma
